Progressive Care Inc. Announces Strongest February in Company History

March 21, 2019
webadmin

MIAMI – March 21,2019 –ProgressiveCare Inc. (OTCQB: RXMD),a personalized healthcare services and technology company, today announcedfurther growth year-over-year in revenue and number of prescriptions filled forFebruary 2019.

InFebruary,the company reported a total of $1.7 million in net revenue, a 17% increase from the same month last year, and a 36% increase in prescriptions filled during the same monthlast year, totaling nearly 26,719prescriptions filled. Despite industry headwinds through reimbursementcompression, network restriction, and formulary reduction, the Companycontinues its upward growth trend for revenues and prescriptions filled. TheCompany credits this growth to superior performance reviews and promotion of value-addedhealthcare service offerings.

“February was another bigmonth for us. Progressive Care exceeded February, 2018 prescription fillings and is moving forwardon major initiatives,” said S. Parikh Mars, CEO of Progressive Care. “We are currentlywrapping up the annual report and working through the acquisition process withlicensing and contracting agencies. We are on track to double our revenues postacquisition of FPRX and are confident that 2019 will lead to continued growth,more record-breaking months, and even bigger milestones as we continue ourmission to revolutionize the pharmacy industry.”

AboutProgressive Care Inc.

Progressive Care Inc. (OTCQB:RXMD), through its PharmCo, LLC, is a South Florida health servicesorganization and provider of prescription pharmaceuticals, compoundedmedications, provider of tele-pharmacy services, the sale of anti-retroviralmedications, medication therapy management (MTM), the supply of prescriptionmedications to long-term care facilities, and health practice risk management.

Cautionary Statement RegardingForward-Looking Statements

Statementscontained herein that are not based upon current or historical fact areforward-looking in nature and constitute forward-looking statements within themeaning of Section 27A of the Securities Act of 1933 and Section 21E of theSecurities Exchange Act of 1934. Such forward-looking statements reflect theCompany’s expectations about its future operating results, performance, andopportunities that involve substantial risks and uncertainties. Thesestatements include but are not limited to statements regarding the intendedterms of the offering, closing of the offering and use of any proceeds from theoffering. When used herein, the words “anticipate,” “believe,” “estimate,”“upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, asthey relate to Progressive Care Inc., its subsidiaries, or its management, areintended to identify such forward-looking statements. These forward-lookingstatements are based on information currently available to the Company and aresubject to a number of risks, uncertainties, and other factors that could causethe Company’s actual results, performance, prospects, and opportunities todiffer materially from those expressed in, or implied by, these forward-lookingstatements.

InvestorRelations Contact:

Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com

PublicRelations Contact:

Kathleen Gonzales, CMW Media
Kathleen@cmwmedia.com
www.cmwmedia.com

Weband Application Development Contact:

Marcello Jaspan, Mass Ventures Corp
Marcello@massventurescorp.com
www.massventurescorp.com

Investors' Presentation